Chi-Ping Huang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Cell death & disease

International journal of urology : official journal of the Japanese Urological Association

Medicine

Cell death and differentiation

China Medical University Hospital

China Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Medical University Hospital

Taiwan

Chairman :: Department of Urology

Chinese Medical University

Taiwan

Assistant Professor :: School of Medicine

China Medical University Hospital

Taiwan

Director of MIS :: Division of minimal invasive surgery, department of Urology

China Medical University Hospital

Taiwan

Attending Surgeon :: Department of Urology

Chi-yi Veterans Hospital

Taiwan

Attending Physician/Chief of ESWL unit :: Division of Urology, Department of Surgery

Taichung Veterans General Hospital

Taiwan

Residencies/Attending Physician :: Division of Urology, Department of Surgery

Education History

China Medical University

Taiwan

PHD :: Clinical Medicine

Publications

Hao Xiang Chen, Shih-Hsin Chang, Der-Yuan Chen, Joung-Liang Lan, Kai-Jieh Yeo, Po-Hao Huang, Chung-Ming Huang, Chi-Ping Huang, Eric Chieh-Lung Chou, Po-Chang Wu
Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms-A randomized controlled trial. Lower urinary tract symptoms (2023)
Shi-Chen Ou, Sheng-Teng Huang, Mei-Chen Lin, Wen-Chi Chen, Chi-Ping Huang, Hung-Jen Lin
Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in Taiwan. International journal of urology : official journal of the Japanese Urological Association 29 (7) (2022)
Jen-Kai Fang, Po-Jen Hsiao, Hung-Chieh Chiu, Chi-Ping Huang
Robot-assisted anatrophic nephrolithotomy for complete staghorn stone. Medicine 101 (34) (2022)
Min Tang, Yin Sun, Chi-Ping Huang, Lei Chen, Bianjiang Liu, Bosen You, Zengjun Wang, Chawnshang Chang
High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signals. Cell death & disease 13 (8) (2022)
Gang Deng, Ronghao Wang, Yin Sun, Chi-Ping Huang, Shuyuan Yeh, Bosen You, Changyong Feng, Gonghui Li, Shenglin Ma, Chawnshang Chang
Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals. Cell death and differentiation 28 (7) (2021)
Fu-Ju Chou, ChangYi Lin, Hao Tian, WanYing Lin, Bosen You, Jieyang Lu, Deepak Sahasrabudhe, Chi-Ping Huang, Vanessa Yang, Shuyuan Yeh, Yuanjie Niu, Chawnshang Chang
Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer. Cell death & disease 11 (11) (2020)
Shi-Chen Ou, Mei-Chen Lin, Hung-Jen Lin, Chi-Ping Huang, Sheng-Teng Huang
Association between erectile dysfunction and fibromyalgia in male patients: A Taiwanese nationwide population-based cohort study. International journal of urology : official journal of the Japanese Urological Association 27 (12) (2020)

Chi-Ping Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chi-Ping Huang